The generation of induced pluripotent stem cells (iPSCs) presents a challenge to normal developmental processes. The low efficiency and heterogeneity of most methods have hindered understanding of the precise molecular mechanisms promoting, and roadblocks preventing, efficient reprogramming. While several intermediate populations have been described^[@R1]-[@R7]^, it has proved difficult to characterize the rare, asynchronous transition from these intermediate stages to iPSCs. The rapid expansion of a minor population of reprogrammed cells can also obscure investigation of relevant processes. Understanding of the biological mechanisms essential for successful iPSC generation requires both accurate capture of cells undergoing the reprogramming process and identification of the associated global gene expression changes. Here we demonstrate that reprogramming follows an orderly sequence of stage transitions marked by changes in cell surface markers CD44 and ICAM1, and a Nanog-GFP reporter. RNA-sequencing (RNA-seq) analysis of these populations demonstrates two waves of pluripotency gene up-regulation, and unexpectedly, transient up-regulation of multiple epidermis-related genes, demonstrating that reprogramming is not simply the reversal of normal developmental processes. This novel high-resolution analysis enables the construction of a detailed reprogramming route map, and this improved understanding of the reprogramming process will lead to novel reprogramming strategies.

Several reports have suggested that reprogramming progresses in a somewhat ordered manner^[@R3],[@R5],[@R6],[@R8]-[@R10]^. In order to identify markers whose expression changed concurrent with pluripotency gene expression we performed time course microarray analysis using a *piggyBac* (PB) transposon-based secondary (2°) reprogramming system^[@R3],[@R11]^ ([Supplementary Figure 2a](#SD1){ref-type="supplementary-material"}). Of a number of candidate cell surface markers, *Cd44* and *Icam1* demonstrated the most dynamic expression changes throughout 2° MEF reprogramming ([Supplementary Figure 2b](#SD1){ref-type="supplementary-material"}). For further investigation we generated an efficient 2° reprogramming system in which doxycycline (dox) mediated induction of the reprogramming factors could be monitored via an mOrange reporter placed after the 2A-peptide-linked reprogramming cassette *c-Myc-Klf4-Oct4-Sox2* (**MKOS**)^[@R12]^, and endogenous *Nanog* promoter activation could be followed by expression of EGFP^[@R13]^ ([Supplementary Figures 3](#SD1){ref-type="supplementary-material"},[4](#SD1){ref-type="supplementary-material"}). Reprogramming cultures were supplemented with Vitamin C (VitC) and an Alk inhibitor (Alki) which enhance reprogramming efficiency^[@R10],[@R14],[@R15]^. In this 2° reprogramming system, Nanog-GFP^+^ cells appeared as early as day 6, and \>60% of mOrange^+^ transgene expressing cells were found to be Nanog-GFP^+^ by day 12 ([Supplementary Figure 5a](#SD1){ref-type="supplementary-material"}). Most mOrange^+^ transgene expressing cells lost Thy1 and gained E-cadherin expression by day4 ([Supplementary Figures 5b,c](#SD1){ref-type="supplementary-material"}). SSEA-1 expression barely changed after day 8, with a gradual gain of Nanog-GFP^+^ cells in both SSEA-1^+^ and SSEA-1^−^ populations ([Supplementary Figure 5d](#SD1){ref-type="supplementary-material"}). Consistent with heterogeneous expression of SSEA1 in iPSCs/ESCs, it was not possible to accurately delineate the reprogramming process using SSEA-1 ([Supplementary Figure 6](#SD1){ref-type="supplementary-material"}). In contrast, the appearance of CD44^−^ and ICAM1^+^ cells at later time points closely correlated with Nanog-GFP expression ([Supplementary Figures 5e,f](#SD1){ref-type="supplementary-material"}). Double staining for CD44 and ICAM1 revealed that a distinct series of population changes occur during reprogramming ([Figure 1](#F1){ref-type="fig"}). Initially, MEFs displayed high CD44 and broad ICAM1 expression with the majority becoming ICAM1^−^ by day 6, along with the appearance of a minor CD44^−^ ICAM1^−^ population. By day 8, CD44^−^ populations appeared enriched, and at day 12 almost all cells displayed an iPSC/ESC-like CD44^−^ ICAM1^+^ profile, over 60% of which expressed Nanog-GFP. Consistent with an observation that Nanog expression is not necessarily a sign of completed reprogramming^[@R16]^, Nanog-GFP^+^ cells were observed even before cells obtained this iPSC/ESC-like phenotype (CD44^−^ ICAM1^+^). Both ICAM1^+^ and ICAM1^−^ sorted MEF demonstrated similar FACS profile changes during reprogramming ([Supplementary Figure 7](#SD1){ref-type="supplementary-material"}). Immunofluorescence for CD44 and ICAM1 revealed that reprogramming is not synchronized even within individual colonies ([Supplementary Figure 8](#SD1){ref-type="supplementary-material"}). Secondary reprogramming of non-polycistronic line 6c^[@R11],[@R14]^ and primary reprogramming using MKOS and OSKM^[@R20]^ PB transposons resulted in similar ICAM1/CD44 profile changes indicating their sutability for use in other systems and contexts ([Supplimentary Figure 9](#SD1){ref-type="supplementary-material"}). These findings demonstrated the asynchronous but stepwise manner of reprogramming and highlighted the potential usefulness of CD44 and ICAM1 to isolate reprogramming intermediate subpopulations.

Next, we aimed to confirm that the observed CD44/ICAM1 profile changes reflected the transition of individual cells from one stage to the next, and not merely the loss of one major population and expansion of another minor population. CD44^+^ ICAM1^−^ (Gate1), CD44^−^ ICAM1^−^ (Gate2) and CD44^−^ ICAM1^+^ (Gate3) populations, either Nanog-GFP^+^ (NG+) or Nanog-GFP^−^ (NG−) were isolated by cell-sorting at day 10 of reprogramming and re-plated in reprogramming conditions ([Figure 2a](#F2){ref-type="fig"}). After 3 days both NG+ and NG− cells progressed in the order of gates 1→2→3 ([Figure 2b](#F2){ref-type="fig"}). This progression correlated well with increased Nanog-GFP^+^ colony forming potential (cfp), with 3NG+ cells displaying similar clonogenicity to fully reprogrammed iPSCs ([Figure 2c](#F2){ref-type="fig"}). Of cells with the same CD44/ICAM1 profile, Nanog-GFP expression correlated with a higher cfp (e.g. 1NG− vs 1NG+).

To more accurately examine the progression of the reprogramming process, cells from each gate were sorted and their CD44/ICAM1/Nanog-GFP expression was re-analysed after 24 hours ([Figure 2d](#F2){ref-type="fig"}). Based on total cell numbers in each gate after 24 hours ([Supplementary Figure 10](#SD1){ref-type="supplementary-material"}), we generated a reprogramming route map representing differences in the efficiency of these stage transitions and in Nanog-GFP^+^ cfp ([Figure 2e](#F2){ref-type="fig"}). Similar results were obtained when each subpopulation was sorted at day8 ([Supplementary Figure 11](#SD1){ref-type="supplementary-material"}). This analysis revealed that reaching a Nanog-GFP^+^ state is a rate limiting step -- as few cells overcame this barrier in the 24 hour assay -- and those that do so reprogram more efficiently than their Nanog-GFP^−^ counterparts, consistent with the role of *Nanog* as an accelerator of reprogramming and the gateway to pluripotency^[@R17],[@R18]^.

To elucidate global gene expression changes during these stage transitions, we carried out RNA-sequencing analysis using a highly multiplexed sample barcoding system^[@R19],[@R20]^ (see Methods Online, [Supplementary Table 1](#SD3){ref-type="supplementary-material"}). Hierarchical clustering using the complete list of differentially expressed genes (DEGs) revealed four major branches; \[MEFs\], \[1NG−/+ and 2NG−\], \[2NG−/+ and 3NG−/+\], and \[3NG+ sorted at day 15 (3NG+D15), iPSCs and ESCs\] ([Figure 3a](#F3){ref-type="fig"}). These clusters correlate well with similarities in cfp of the respective subpopulations ([Figure 2c](#F2){ref-type="fig"}). There was a prominent gene expression difference between 3NG+ and 3NG+D15, with the latter being more similar to iPSCs and ESCs ([Figure 3a](#F3){ref-type="fig"}, [Supplementary Figures 12a,c](#SD1){ref-type="supplementary-material"}), possibly reflecting the observed difference in cfp in the absence of dox ([Supplementary Figure 13](#SD1){ref-type="supplementary-material"}). The DEGs between these two populations may be involved in the establishment of an exogenous factor independent self-renewal state. Principal component analysis clearly distinguished 2NG+ from 3NG− cells, consistent with the higher probability of the former to reach the 3NG+ state within 24 hours ([Supplementary Figures 11c](#SD1){ref-type="supplementary-material"} and [12b](#SD1){ref-type="supplementary-material"}). DEGs could be classified into five distinct expression pattern groups (A to E) ([Figure 3a](#F3){ref-type="fig"}, [Supplementary Tables 2](#SD4){ref-type="supplementary-material"},[3](#SD5){ref-type="supplementary-material"}). Group A contained readily down-regulated fibroblast-related genes. Group D comprised factors gradually up-regulated toward iPSCs, where ESC genes were highly enriched (*P*≤0.000367) ([Figure 3c](#F3){ref-type="fig"}). However Group C, which contained genes up-regulated at early stages and maintained throughout reprogramming, also included some pluripotency related factors. To extend this finding, we examined the expression pattern of 22 pluripotency-related genes in our data set^[@R21],[@R22]^. Interestingly, 8 pluripotency genes, including endogenous *Oct4* (*Pou5f1*) were already up-regulated at the 1NG+/2NG− stages to the level found in 3NG+ cells ([Figure 3b](#F3){ref-type="fig"} Early), while 14 pluripotency genes were more gradually up-regulated in the later stage reprogramming populations ([Figure 3b](#F3){ref-type="fig"} Late, [Supplementary Table 4](#SD6){ref-type="supplementary-material"}). This early and late pluripotency gene up-regulation was confirmed at the single cell level^[@R5]^ ([Figure 3e](#F3){ref-type="fig"}), highlighting the high resolution of the CD44/ICAM1 sorting system.

We also identified two additional gene expression patterns displaying transient up-regulation (Group B) or down-regulation (Group E) exclusively in the intermediate stages of reprogramming. This finding indicates that reprogramming from MEFs to iPSCs is not simply the loss of MEF genes and gain of ESC genes. Gene Ontology analysis revealed that genes related to ectoderm/epidermis development and keratinocyte differentiation were highly enriched in Group B (*P*≤0.000274) ([Figures 3c,d](#F3){ref-type="fig"}, [Supplementary Tables 3](#SD5){ref-type="supplementary-material"}-[5](#SD7){ref-type="supplementary-material"}). While Sfn and Krt17 were barely detectable by immunofluorscence in MEFs and iPSCs, transient up-regulation was observed in the intermediate stages of reprogramming ([Supplementary Figure 14](#SD1){ref-type="supplementary-material"}). Single cell PCR confirmed co-expression of epidermis genes (Ehf, Ovol1) with early pluripotency genes in the 1NG−/+ stage ([Figure 3e](#F3){ref-type="fig"}). Consistent with our data, analysis of three published microarray data sets incorporating partially reprogrammed iPSCs (piPSCs)^[@R1]^, a time course experiment^[@R3]^ and a subpopulation analysis with Thy1, SSEA-1 and Oct4-GFP^[@R6]^ confirmed transient epidermal gene expression during reprogramming ([Supplementary Figures 15](#SD2){ref-type="supplementary-material"}-[17](#SD1){ref-type="supplementary-material"}, [Supplementary Tables 6](#SD8){ref-type="supplementary-material"}-[8](#SD10){ref-type="supplementary-material"}). Partially reprogrammed cells from B cells also displayed similar epidermis gene expression^[@R4]^, while Oct4, Sox2 two factor-reprogramming of MEFs did not^[@R23]^. Therefore, this intermediate state could be a consequence of the use of Klf4 which is important for efficient reprogramming and demonstrates the reprogramming process is not simply reversion of normal differentiation (Summarized in [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). It would be intriguing to investigate if similar transient gene expression changes can be seen in reprogramming of ectoderm or endoderm lineages. Down-regulation of these epidermis genes coincided with up-regulation of "late" pluripotency genes. Future examination of this rapid switch in gene expression may provide a novel insight into the molecular mechanism of reprogramming.

The integrative data analysis described above demonstrated this CD44/ICAM1/Nanog-GFP marker system, uniquely, could provide high-resolution information during late pluripotency gene up-regulation enabling discrimination of 'reprogramming' from 'expansion of reprogrammed cells' ([Figure 3b](#F3){ref-type="fig"}, [Supplementary Figures 16b](#SD1){ref-type="supplementary-material"}, [17f](#SD1){ref-type="supplementary-material"},). This system also refines investigation of the kinetics of reprogramming. It has recently been shown that VitC increases reprogramming efficiency by facilitating H3K9 demethylation^[@R7]^ and that reprogramming factors fail to bind trimethylated H3K9 rich regions in the initial stages of reprogramming^[@R24]^. We carried out reprogramming in the absence of VitC and observed not only a decrease in the iPSC colony number, but also a marked delay in the transition from one stage of reprogramming to the next ([Supplementary Figure 18](#SD1){ref-type="supplementary-material"}). Similar analyses can be performed using our marker system to investigate the mechanism of action of other factors that alter reprogramming efficiency. Isolation and analysis of subpopulations affected by these factors could reveal the downstream genes specifically involved in, and required for, successful reprogramming. Further studies using this high resolution analysis system have the potential to make a significant contribution towards revealing the molecular mechanisms of reprogramming.

METHODS {#S2}
=======

Vector construction {#S3}
-------------------

The piggyBac (PB) transposon PB-TAP containing the tetO~2~ promoter, an attR1R2 Gateway cloning cassette (Invitrogen) and rabbit β-globin poly A signal, was provided by A. Nagy. To minimize silencing of the reprogramming vector, a chicken β-globin insulator^[@R30]^, and a human lamin B2 (LMB2) replicator^[@R31]^ were inserted in PacI site between PB 3′TR and the tetO~2~, EcoRV site between rabbit β-globin poly A signal and PB 5′TR, respectively, to generate PB-TAP IRI. The BamHI fragment containing loxP flanked MKOS reprogramming cassette followed by ires-mOrange (2LMKOSimO) from pCAG2LMKOSimO^[@R12]^ were inserted into a Gateway entry vector pENTR 2B (Life Technologies), to generate attP2LMKOSimO pENTR. Finally the attP2LMKOSimO cassette was Gateway cloned into the PB-TAP IRI to yield reprogramming PB transposon PB-TAP IRI attP2LMKOSimO. Similarly, reprogramming PB transposon PB-TAP IRI 2LOSKMimO was generated after transferring the OSKM reprogramming cassette^[@R32]^ into attP2LMKOSimO pENTR replacing the MKOS cassette. Sequences of the plasmids are available upon request.

Generation of a primary iPSC line D6s4B5 {#S4}
----------------------------------------

12.5 d.p.c. embryos were obtained from Rosa-rtTA/rtAT, Nanog-GFP/+, Col1a1^+/+^ mice which were derived by a crossing TNG mice^[@R13]^ and B6;129-*Gt(ROSA)26Sor^tm1(rtTA\*M2)Jae^ Col1a1^tm2(tetO-Pou5f1)Jae^*/J (The Jackson Laboratory). The embryos were decapitated, eviscerated, dissociated with 0.25% trypsin, 0.1% EDTA and plated in MEF medium (GMEM, 10% FBS, penicillin-streptomycin, 1× Non-Essential Amino Acids (Invitrogen), 1 mM Sodium Pyruvate, 0.05 mM 2-Mercaptoethanol ). The PB-TAP IRI attP2LMKOSimO (500 ng) and pCyL43 PB transposase expression vector^[@R33]^ (2 μg) were introduced into the MEFs via Nucleofection (Amaxa) as before^[@R11]^, and cells were cultured in the ES cell medium (MEF medium supplemented with 1000 U ml^−1^ Leukemia inhibiting factor (LIF)) in the presence of 1.0 μ ml^−1^ doxycycline (dox) (Sigma) for an initial 8 days and thereafter 0.5 μg ml^−1^ dox. Pluripotency of a clonal iPSC line D6 was confirmed by teratoma formation and a subclone D6s4B5 was used for secondary reprogramming. For comparing CD44 and ICAM1 profiles of primary reprogramming with PB-TAP IRI attP2LMKOSimO and PB-TAP IRI 2LOSKMimO vectors, MEF were nucleofected as above and cultured in the presence of 1.0 μ ml^−1^ dox, Vitamin C (10 μg ml^−1^) (Sigma) and Alk inhibitor (500 nM) (A83-01, TOCRIS Bioscience).

Secondary reprogramming {#S5}
-----------------------

Each chimeric embryo were harvested at 12.5 d.p.c., dissociated and cultured in MEF medium. One twentieth of the dissociated cells were exposed to dox (300 ng ml^−1^) for 2 days and the proportion of transgenic (Tg) MEFs was measured by FACS analysis of mOrange expression. For FACS time course and colony counting experiments secondary Tg MEFs were diluted to 5% and 30% by addition of wild type 129 MEFs and plated in gelatinized 6 well-plate at 1×10^5^ cells per well (5,000 and 30,000 Tg MEFs per well, respectively). For sorting experiments MEFs were plated at 2×10^5^ cells per gelatinized 100 mm plate (1×10^4^ Tg MEFs per plate). Cells were cultured in Reprogramming medium, which is ES cell medium supplemented with dox (300 ng ml^−1^), Vitamin C (10 μg ml^−1^) and Alki (500 nM). Medium was changed every 2 days.

Flow Cytometry and cell sorting {#S6}
-------------------------------

Surface marker analysis was performed with the following eBioscience antibodies (catalogue number; dilution): CD54/ICAM-1-biotin (13-0541; 1/100), CD44-biotin (17-0441; 1/100), CD44-APC (17-0441; 1/300), Streptavidin-PE-Cy7 (25-4317-82; 1/1500), SSEA-1-647 (51-8813; 1/50), CD324/E-Cadherin-biotin (13-3249; 1/100), Thy1-APC (17-0902, 1/300), CD2-biotin (13-0029; 1/100). For sorting experiments dead cells were excluded using DAPI nucleic acid stain (Invitrogen) (0.5ng/mL). Cells were incubated in 0.25% Trypsin, 1mM EDTA (Life Technologies) for 1-2 minutes at 37°C, harvested in GMEM containing 10% FCS and counted. Staining was carried out in FACS buffer (2% FCS in PBS) at \~1×10^6^ cells ml^−1^ for 15-30 min at 4°C, and which was followed by washing with FACS buffer, sorting and/or analysis with FACSAriaII and LSRFortessa (both BD Biosciences), respectively. Excitation laser lines and filters used for each fluorophore are summarized in [Supplementary Table 9](#SD11){ref-type="supplementary-material"}. Data were analysed using FlowJo software (Tree Star). Intact cells were identified based on forward and side light scatter, and subsequently, analysed for fluorescence intensity. Additional gating was carried out as outlined in [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}. For colony formation assays, sorted cells were plated on γ-irradiated MEFs in 12-well plates at 3.5×10^3^ cells per well. Nanog-GFP^+^ colonies were quantified 10 days post sort. For 24 hour or time course analysis, sorted cells were plated in gelatinized 48-well plate at 1×10^4^ cells per well. In both cases, cells were cultured in Reprogramming medium after sort.

Immunofluorescence and confocal microscopy imaging {#S7}
--------------------------------------------------

Images of cells stained with CD54/ICAM-1-biotin (1/100 dilution), CD44-APC (1/300 dilution) antibodies and Streptavidin-PE-Cy7 (1/1500 dilution) described above were captured with a confocal microscope (Leica TSC SP2) and Leica confocal software. Cells stained with anti-Krt17 (LifeSpan BioSciences), anti-Sfn (Sigma) antibodies and anti-Rabbit IgG CF633 secondary antibody (Sigma) were imaged with a fluorescence microscopy (Olympus).

Multiplexed RNA Sequencing and data analysis {#S8}
--------------------------------------------

RNA was isolated with TRI reagent (Sigma) following the manufacturer's instructions. RNA quality and concentration was determined using the Agilent 2100 Bioanalyzer (Agilent Technologies). Using 10ng RNA, reverse transcription with barcoded primers, cDNA amplification and sequencing with Illumina HiSeq 2000 was performed as previously described^[@R19],[@R20]^. Quality control of the obtained reads and alignment to the mouse reference genome (NCBI37/mm9) was performed using the GeneProf web-based analysis suite with default parameters^[@R25]^. Gene expression read counts were exported and analysed in R to identify differentially expressed genes (DEGs), using the edgeR and DESeq Bioconductor libraries^[@R26]-[@R28]^. For both methods, low expression transcripts (less than 13 reads in all samples) were filtered out and P-values were adjusted using a threshold for false discovery rate (FDR) ≤ 0.05. Genes listed as DEGs by both methods in any two subpopulation comparison indicated in [Supplementary Figure 6a](#SD1){ref-type="supplementary-material"} (total 3,171) were used for further analysis. Hierarchical clustering and K-means clustering (*K*=5) was performed using Cluster 3.0 and Java Treeview was used for visualisation^[@R34],[@R35]^. This multiplexed RNA-sequencing technology reads only the 5′ end of transcript, thus detecting only endogenous *Oct4* and *Sox2*. *Nanog* expression was detectable in Nanog-GFP^−^ populations due to the reporter system. Principal Components Analysis (PCA) was performed in R and plotted with the scatterplot3d library^[@R36]^. Gene ontology (GO) enrichment was calculated using the DAVID functional annotation bioinformatics tool^[@R29]^. GO term enrichment analysis was carried out with a modified Fisher Exact p-value. The three additional published studies^[@R1],[@R3],[@R6]^ (GEO accession number GSE21757, GSE14012, GSE42379) were analysed in a similar way. For the time course data the analysis was performed as following: data were RMA^[@R37]^ normalised using the Expression Console from Affymetrix and, since no replicates were provided, fold changes (FC) between each two samples were calculated in Excel. Genes with more than 1.5 FC were classified as DEGs. For the Plath and Polo dataset, data were RMA normalised using the 'affy' package^[@R38]^ in R and DEGs were identified using the 'limma' package^[@R38]^ in R with FC\>=1.5 and FDR\<=0.05 or FC\>=1.5 where no replicates were available. Subsequently, K-means clustering of the identified DEGs was performed for all studies. Selected gene expression data shown as relative expression against the highest signal among the samples using an averaged signal value (reads per million) of duplicates/triplicates.

Single-cell gene expression analysis {#S9}
------------------------------------

Single cell qPCR was performed as described previously^[@R5]^ with slight modifications. Briefly, 22 sets of TaqMan Gene Expression assays (Applied Biosystems, [Supplementary Table 9](#SD11){ref-type="supplementary-material"}) were pooled at a final concentration of 180 nM per primer set and 50 μM per probe. Individual cells were sorted directly into 10 μl RT-PreAmp Master Mix (5 μl of CellsDirect Reaction Mix (Invitrogen), 2.5 μl of pooled assays, 0.2 μl of SuperScript III (Invitrogen), 1.3 μl of water) using FACSAria II. Cell lysis and sequence-specific reverse transcription were performed at 50°C for 15 min. The reverse transcriptase was inactivated by heating to 95°C for 2 min. Subsequently, in the same tube, cDNA went through sequence-specific amplification by denaturing at 95C for 15 s, and annealing and amplification at 60°C for 4 min for 22 cycles. Preamplified products were diluted 5-fold with water and analysed in 48.48 Dynamic Arrays on a BioMark System (Fluidigm) following the Fluidigm protocol. Ct values were calculated and visualized using BioMark Real-time PCR Analysis software (Fluidigm). Each assay was performed in replicate.
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![FACS analysis during 2° reprogramming of MEF with CD44/ICAM1 double staining\
Loss of CD44 expression was rapidly followed by ICAM1 upregulation and Nanog-GFP expression. By day 12 the majority of cells displayed an ICAM^+^/CD44^−^ ESC-like profile. Red; Nanog-GFP^−^ cells, Green; Nanog-GFP^+^ cells.](emss-53165-f0001){#F1}

![CD44/ICAM1 subpopulations represent distinct stages of reprogramming\
**a.** Nanog-GFP^+^ (NG+) and Nanog-GFP^−^ (NG−) cells were subdivided into CD44^+^ ICAM1^−^ (Gate1), CD44^−^ ICAM1^−^ (Gate 2) and CD44^−^ ICAM1^+^ (Gate 3) populations at day 10 of reprogramming. **b.** FACS analysis of sorted subpopulations after 3 day culture in the presence of dox. **c.** Relative probability to generate Nanog-GFP^+^ iPSC colonies from each subpopulation compared to fully reprogrammed iPSCs. Error bars represent standard deviation, n=3 **d.** CD44/ICAM1/Nanog-GFP expression was re-analysed 24 hours after sorting. **e.** Major transitions (\>500 cells) of each populationwithin 24 hours. Y axis indicates relative colony formation potential after an additional 10 days. Arrow size reflects relative cell numbers.](emss-53165-f0002){#F2}

![Global gene expression changes during the stage transition\
**a.** Hierarchical clustering of samples with DEGs and expression heat map. Groups A-E represent different expression patterns. b. Early and late up-regulation of pluripotency-related genes. Black and red asterisks indicate early and late pluripotency genes respectively as previously identified by single cell qPCR^[@R5]^. **c.** Epidermis gene and stem cell gene enrichment in gene list B and D respectively. **d.** Transient up-regulation of 18 epidermis/keratinocyte-related genes during reprogramming. **e.** Single-cell gene expression analysis. Each square represents one reaction chamber from one cell. Colour corresponds to ΔCT value as shown in legend at right.](emss-53165-f0003){#F3}
